Literature DB >> 3292238

Conformational alterations detected by circular dichroism induced in the normal ras p21 protein by activating point mutations at position 12, 59, or 61.

A Valencia1, L Serrano, R Caballero, P S Anderson, J C Lacal.   

Abstract

Activation of the oncogenic potential of ras oncogenes occurs by point mutations at codons 12, 13, 59, 61, and 63 of the sequences that codify for its product, a 21-kDa protein designated as p21. This activation has been postulated by computer models as modifiers of the structure of the protein, which may alter its biochemical and biological activities. We have expressed in bacteria the normal ras p21 and five mutated p21 proteins with mutations at positions 12, 59, 61, 12 plus 59, and 12 plus 61. Purification was carried out by solubilization from bacterial pellets in 7 M urea and chromatography through a Sephadex G-100 column to obtain greater than 95% purified proteins. Circular dichroic (CD) spectra showed that the normal protein and that activated by substitution of Ala59 to Thr59 are very similar in their overall structure. By contrast, point mutations affecting either 12 or 61 residues substantially altered the structure of the proteins. When the parameters of Chen et al. [Biochemistry II, 4120-4131 (1972)] were applied to the CD spectra, both normal and thr59-mutated ras proteins showed a less organized structure than mutated proteins at position 12 or 61. Since the Thr59 mutant has more similar transforming activity than other activated proteins, but a GTPase activity similar to that of the normal protein, our results support the hypothesis that there is more than one mechanism of activation of the ras p21 protein. One of these mechanisms involves important structural alterations by point mutations at position 12 or 61 which reduce the GTPase activity of the protein. Another mechanism will be that induced by a substitution of Ala59 to Thr59 which does not substantially alter the protein conformation. A putative alternative mechanism for the activation of this mutant is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292238     DOI: 10.1111/j.1432-1033.1988.tb14143.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  Circular dichroic study of conformational changes in ovalbumin induced by modification of sulfhydryl groups and disulfide reduction.

Authors:  P P Batra; K Sasa; T Ueki; K Takeda
Journal:  J Protein Chem       Date:  1989-10

2.  Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease.

Authors:  Christopher A Seid; Kathryn M Jones; Jeroen Pollet; Brian Keegan; Elissa Hudspeth; Molly Hammond; Junfei Wei; C Patrick McAtee; Leroy Versteeg; Amanda Gutierrez; Zhuyun Liu; Bin Zhan; Jonathan L Respress; Ulrich Strych; Maria Elena Bottazzi; Peter J Hotez
Journal:  Hum Vaccin Immunother       Date:  2016-10-13       Impact factor: 3.452

3.  Interaction of a novel fluorescent GTP analogue with the small G-protein K-Ras.

Authors:  Seigo Iwata; Kaori Masuhara; Nobuhisa Umeki; Yasushi Sako; Shinsaku Maruta
Journal:  J Biochem       Date:  2015-07-15       Impact factor: 3.387

4.  Detection of a rare point mutation in Ki-ras of a human bladder cancer xenograft by polymerase chain reaction and direct sequencing.

Authors:  S M Grimmond; D Raghavan; P J Russell
Journal:  Urol Res       Date:  1992

5.  Sequence-specific 1H and 15N resonance assignments and secondary structure of GDP-bound human c-Ha-Ras protein in solution.

Authors:  Y Muto; K Yamasaki; Y Ito; S Yajima; H Masaki; T Uozumi; M Wälchli; S Nishimura; T Miyazawa; S Yokoyama
Journal:  J Biomol NMR       Date:  1993-03       Impact factor: 2.835

6.  Parkinson disease-associated mutation R1441H in LRRK2 prolongs the "active state" of its GTPase domain.

Authors:  Jingling Liao; Chun-Xiang Wu; Christopher Burlak; Sheng Zhang; Heather Sahm; Mu Wang; Zhong-Yin Zhang; Kurt W Vogel; Mark Federici; Steve M Riddle; R Jeremy Nichols; Dali Liu; Mark R Cookson; Todd A Stone; Quyen Q Hoang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.